Maharani Medi-Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.60%
(FY 2023)
- Profit -15.31%
(FY 2023)
- Ebitda -10.96%
(FY 2023)
- Net Worth 4.24%
(FY 2023)
- Total Assets 15.98%
(FY 2023)
About Maharani Medi-Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narendrabhai Bhuptani, Mita Bhuptani, and Vishesh Bhuptani serve as directors at the Company.
- CIN/LLPIN
U29299GJ2007PTC050082
- Company No.
050082
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maharani Medi-Care Private Limited offer?
Maharani Medi-Care Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Intraocular Lenses, Orthopedic Equipment & Supplies, Hip Prosthesis, Electrical Conduits and Fittings, Cable Raceways, Drilling Bits, Collets and Chucks, Carbide Drills, Access Control Systems, Time Attendance Systems.
Who are the key members and board of directors at Maharani Medi-Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishesh Bhuptani  | Director | 23-May-2016 | Current |
| Narendrabhai Bhuptani | Director | 23-Feb-2007 | Current |
| Mita Bhuptani | Director | 23-Feb-2007 | Current |
Financial Performance of Maharani Medi-Care.
Maharani Medi-Care Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.6% decrease. The company also saw a substantial fall in profitability, with a 15.31% decrease in profit. The company's net worth moved up by a moderate rise of 4.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maharani Medi-Care?
In 2023, Maharani Medi-Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maharani Medi-Care?
Unlock and access historical data on people associated with Maharani Medi-Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maharani Medi-Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharani Medi-Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
